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Abstract.  The conversion of determined adipoblasts to 
fully differentiated adipocytes requires appropriate en- 
vironmental conditions. A  strict dependence on cell 
confluence and a  facilitation by glucocorticoid hor- 
mones have previously been described.  We have found 
that agents that are capable of activating protein kinase 
C,  such as basic fibroblast growth factor and phorbol 
esters, inhibit the differentiation of the adipogenic cell 
line TA1  without stimulating cell growth. Here we de- 
scribe the sequence and characterization of a  cDNA 
(clone 5) that detects an RNA, the expression of 
which is enhanced by glucocorticoids and increasing 
cell density. In contrast, activators of protein kinase C 
including basic fibroblast growth factor, phorbol es- 
ters, and synthetic diacylglycerols inhibit clone 5 gene 
expression. It appears that clone 5 expression is 
closely linked to environmental and hormonal factors 
that promote the differentiation of adipogenic cells. 
T 
HE hormonal environment in which a stem cell finds 
itself is likely to be a major determinant controlling its 
decision to continue replicating or to express its ter- 
minally differentiated phenotype. The process of differentia- 
tion is generally reflected by the de novo synthesis of gene 
products that define the specific functions of that cell type. 
Thus erythroid cells will express globins,  B lymphocytes 
will express  immunoglobulins, and myocytes will express 
novel  contractile  proteins.  Although  the  mechanisms  by 
which the respective genes are activated remain uncertain, 
it seems that, as a rule, progenitor cells do not express func- 
tions characteristic of the differentiated phenotype while ac- 
tively growing. It is clear that environmental or hormonal 
signals must participate  in directing the cell to  withdraw 
from the cell cycle and to progress towards the differentiated 
state. For example, addition of mitogenic stimuli such as se- 
rum to myoblasts stimulates these cells to continue cycling 
and at the same time represses all morphological and bio- 
chemical markers of myogenic differentiation (Buckingham, 
1977; Devlin and Konigsberg,  1983;  Nguyen et al.,  1983; 
Olson et al., 1983).  Removal of mitogens is followed by the 
expression of such markers. Despite the apparent clarity of 
such phenomena, both the nature of the molecular switch 
that controls the decision to differentiate and the mechanisms 
by which the cell senses and communicates its environmental 
status to that switch remain obscure (Levenson and Hous- 
man,  1981). 
We have been particularly interested in understanding the 
mechanisms by which hormonal cues dictate the ability (or 
inability) of adipogenic stem cells to differentiate into mature 
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adipocytes. TA1 adipoblasts were isolated from the mesen- 
chymal stem cell line, 10-I1/2, after treatment with 5-azacyti- 
dine (Chapman et al.,  1984);  Taylor and Jones (1979)  first 
reported that 10"I"1/2 cells have the potential to differentiate 
into myocytes, chondrocytes, and adipocytes after exposure 
to  this drug.  When maintained at  low density, TA1  cells 
resemble fibroblasts and do not express gene products char- 
acteristic of the mature adipocyte.  However,  when main- 
tained at confluence spontaneous differentiation occurs,  a 
process that can be markedly accelerated by treatment with 
glucocorticoid hormones or the nonsteroidal antiinflamma- 
tory drug, indomethacin (Chapman et al.,  1985;  Knight et 
al.,,  1987). 
In contrast, if cells are maintained at low density, even in 
the presence of an inducing agent such as  indomethacin, 
differentiation-specific  genes are not activated (Knight et al., 
1987).  Moreover,  continual refeeding drives TA1  cells to 
proliferate but even at high density prevents them from ex- 
pressing differentiated functions (Chapman,  1986;  see be- 
low). Thus it appears that only when the cells are at high den- 
sity and not under continual mitogenic stimulation will they 
undergo the transition to the differentiated state. 
In this manuscript we describe the isolation and sequence 
of a cDNA (clone 5) that detects a glucocorticoid-inducible 
RNA in TA1 cells, the abundance of which increases with 
increasing cell density and decreases dramatically after treat- 
ment with FCS or basic fibroblast growth factor (bFGF).' 
1. Abbreviations used in this paper:  aFGF, acidic fibroblast growth factor; 
bFGF,  basic fibroblast  growtb  factor;  diCs,  synthetic  diacylglycerol,  sn- 
1,2-dioctanoylglycerol;  EGF,  epidermal  growth  factor;  PDGE  platelet- 
derived growth factor; PKC, protein kinase C; SSPE, 0.18 M NaCI,  10 mM 
NaH2PO4, pH 7.7, 1 mM EDTA. 
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tein kinase C (PKC) prevents TA1 cells from differentiating 
and simultaneously inhibits the expression of clone 5 RNA. 
Suppression of clone 5 RNA expression by FGF or phorbol 
esters occurs in actively growing cells indicating that this 
effect is likely to be independent of the mitogenic activity of 
these factors. These studies suggest that activation of PKC 
prevents conversion of TA1 cells to the differentiated pheno- 
type without inducing cell growth. Finally, although the fol- 
lowing hypothesis is not directly tested by this work, the pat- 
tern of regulation of clone 5 gene expression leads us to 
speculate that the clone 5 protein may be required, though 
not sufficient, for the triggering of adipocyte differentiation. 
Materials and Methods 
Cell Culture 
TA1  cells (Chapman et al.,  1984)  were grown in Eagle's basal medium 
(BME) (Gibco, Grand Island, NY) supplemented with 10% FCS (lot No. 
507585,  Irvine Scientific, Santa Ana, CA). All serum used was heat inacti- 
vated at 55°C for 30 rain. Cultures were grown in either 35-ram wells (6- 
well plate) or 100-ram dishes at 37°C in a humidified incubator at 5% CO2 
atmosphere. 
Acidic flbroblast growth factor (aFGF)  and bFGF were a  gift of Dr. 
D. Gospodorowicz  (University  of  California,  San  Francisco).  Crude 
platelet-derived growth factor (PDGF) was a  gift of Dr.  L.  T.  Williams 
(University of California, San Francisco). Epidermal growth factor (EGF) 
and partially purified bFGF were from Collaborative Research, Inc. (Bed- 
ford, MA). The phorbol esters tetradecanoylphorboM3-acetate (TPA) and 
phorbol dibutyrate were from Sigma Chemical Co. (St. Louis, MO); they 
were dissolved in DMSO at 1,000×  concentrations so that the final DMSO 
concentration  was  never  >0.1%.  The  synthetic  diacylglycerol,  sn-l,2- 
dioctanoylglycerol (diCs)  was  from  Avanti  Polar  Lipids  (Birmingham, 
AL). diC8 was stored at 5,000x concentrations in DMSO. Dexamethasone 
and indomethacin (Sigma Chemical Co.) were made up in 95 % ethanol and 
used at final concentrations of 1 IxM and  125  laM,  respectively. 
RNA Isolation 
Two methods were used for the isolation of RNA from TA1 cells. Total cel- 
lular RNA was isolated using the method of Chirgwin et al. (1979).  Briefly, 
cells were suspended in 4 M guanidinium-thiocyanate, 25 mM sodium ci- 
trate, 0.2% N-laurylsarcosine, 0.2 mM 2-mercaptoethanol. The resulting 
cell lysate was layered on a 5.7 M cesium chloride solution and centrifuged 
at 80,000 g for 19 h. The RNA pellet was collected and its concentration 
was determined by reading absorbance at 260 nm. Cytoplasmic RNA was 
isolated as follows: cells were collected by trypsinization, washed once with 
PBS, and pelleted in a microfuge tube. The cell pellet was taken up in 250 
gl of chilled lysis buffer (25 mM Tris, pH 7.4,  130 mM NaCI, 50 mM KCI, 
3 mM MgCI2,  1% NP-40) and vortexed for 30 s. The nuclei were pelleted 
by centrifugation for 1 min. The supernatant solution was brought to 0.2 % 
SDS and 10 mM EDTA, and extracted with phenol/chloroform, then chloro- 
form, and once more with phenol/chloroform. RNA was precipitated with 
NaCI and ethanol. 
Analysis of  RNA 
5-10 lag of total RNA was treated with 2.2 M formaldehyde in 50% forma- 
mide,  10 mM NaH2PO4,  pH 7.0, at 55°C for 15 rain. Samples were then 
subjected to electrophoresis in a 1.4% agarose-formaldehyde gel containing 
2.2 M  formaldehyde, 20 mM morpholine propane sulfonic acid, pH 7.0, 
5 mM sodium acetate, and 1 mM EDTA (Lehrach et al.,  1977).  The gels 
were stained with 10 lag/ml ethidium bromide and destained with several 
changes of 10 mM NaH2PO4, pH 7.0. RNA was then transferred to nitro- 
cellulose using 20x  SSPE  (Ix  SSPE  =  0.18  M  NaC1,  10  mM  NaH2- 
PO4,  pH  7.7,  1 mM  EDTA)  as previously described (Danielsen et al., 
1986).  RNA was also analyzed using a "slot blot" method. 2-5 lag of total 
RNA was dissolved in 20x SSPE and heated to 50°C for 10 min. The RNA 
solutions were then directly applied to nitrocellulose using the Schleicher 
& Schuell manifold II apparatus (Schleicher & Schuell, Inc., Keene, NH). 
Blots were prehybridized in H buffer (50% formamide, 5  × SSPE, 0.t% 
SDS, 2× Denhardt's solution [Ix Denhardt's solution =  0.02% wt/vol each 
of BSA, polyvinylporrolidone, and Ficoll], 0.5 mg/ml yeast RNA, and 0.1 
mg/ml denatured and sheared salmon sperm DNA) at 42°C for 1 h. Blots 
were hybridized in H buffer containing radioactive probe for  12-24 h at 
60°C. 32P-labeled probes were made using the Riboprobe system (Melton 
et al., 1984).  Blots were twice washed at 65°C for 30 min in 0.2  ×  SSPE, 
0.1%  SDS,  and autoradiographed.  Quantitative  results were obtained by 
scanning autoradiograms of slot blots with an optical densitometer. To cor- 
rect for differences in the amount of RNAs loaded per slot, results were nor- 
malized to signals generated by probing with I~-actin (Gunning et al., 1983; 
Chapman et al.,  1985).  In all cases, equal amounts of RNA were loaded 
per sample (based on UV absorbance). In the case of Northern blots, this 
was confirmed by observing equal fluorescence in all lanes of gels stained 
with ethidium bromide. In the case of the slot blots, equal amounts were 
loaded per slot; we never detected changes in actin hybridization levels for 
RNA from cells treated with serum or growth factors. Riboprobe was re- 
moved by washing the filters in boiling water.  Filters were then subject to 
prehybridization and hybridization as above, but actin probe was generated 
using the random hexanucleotide priming method with the large fragment 
of DNA polymerase I (Feinberg and Vogelstein, 1983).  Hybridization was 
carried out at 42°C and washes at 50°C. 
Isolation of  a Near-full-length Clone 5 cDNA 
A  cDNA library representing TAI  adipocyte mRNA in the vector Lgtl0 
(Chapman et al., 1984) was screened for clone 5-containing inserts. Esche- 
richia coli strain C600 was infected with phage and plated at a density of 
",,10,000 plaques/90-mm dish. Nitrocellulose filter disks (BA85, 0.45  I.tM 
x  82 mm, Schleicher & Schuell, Inc.) with transferred phage were dena- 
tured (0.5 N NaOH,  1.5 M  NaC1 for 5 min), neutralized (0.5  M Tris [pH 
7.4l, 3 M NaCI for 5 mirt), and washed (2× SSPE for 5 min) before baking. 
The filters were prehybridized as described under blotting of RNA except 
that hybridizations were done at 42°C and washing at 50°C. Probe was pre- 
pared by labeling the original clone 5 cDNA (Chapman et al.,  1984) with 
32p using the random hexanucleotide priming method (see above). 
Sequencing was performed using the dideoxy technique (Sanger et al., 
1977) using Ml3mpll and M13mpl8 (reviewed by Yanisch-Perron et al., 
1985) as vectors and the M13 15-bp or 17-bp universal primers (Pharmacia 
Fine Chemicals, Piscataway,  N J). Sequence analysis was performed using 
National Institutes of Health (NIH)-sponsored BIONET  National Com- 
puter Resource for Molecular Biology (grant No.  1 U41  RR-01685-03). 
Results 
Clone 5 RNA Is Induced upon Differentiation 
of TA1 Cells 
Differentiation  of TA1 cells can easily be monitored by detec- 
tion of RNAs that are expressed specifically in the adipocyte 
but not in the adipoblast.  As an example (Fig.  1) clone 28 
RNA (also referred to as aP2 by others [Hunt et al.,  1986]) 
is not expressed in adipoblasts (day 1) but is expressed abun- 
dantly in adipocytes (day 14); for reference, day 0 is the first 
day the cells are judged to have formed a confluent mono- 
layer. 
We have been characterizing the expression of a variety of 
genes  that are  activated  during the differentiation of TA1 
cells. Among the cDNAs we have isolated (Chapman et al., 
1984) some correspond to RNAs that are expressed before 
differentiation  albeit  at  lower  levels  than  in  differentiated 
adipocytes.  One of these, clone 5,  corresponds to an RNA 
that is both increased during adipogenic conversion and also 
by treatment of TA1 cells with glucocorticoid hormones. As 
seen in Fig.  1, clone 5 RNA increases approximately three- 
to  fivefold  in  the  adipocyte,  and  in  both  adipoblasts  and 
adipocytes it is induced two- to threefold by dexamethasone. 
The initial isolation of the clone 5 eDNA was from a TA1 
library,  prepared from dexamethasone-treated cells,  which 
was  differentially  screened  with  radioactive  probes  from 
low-density adipoblasts (in which clone 5 RNA is extremely 
scarce;  see below) and dexamethasone-treated adipocytes. 
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RNAs in TAI cells before and 
after differentiation. Cells were 
harvested on day 1 or 13, after 
not being refed since day  -2 
or  day  10,  respectively.  + 
lanes  indicate  that  the  cells 
were treated for 2 d with 1 ~Vl 
dexamethasone  before  har- 
vest.  Total cellular  RNA was 
subjected  to  electrophoresis 
through  an  agarose  gel  and 
transferred  to  nitrocellulose. 
The  filter  was  then  probed 
with  3-'P-labeled cDNAs  cor- 
responding  to  13-actin (A), 
clone 28 (28);  or with -a-'P-la- 
beled  RNA corresponding  to 
clone 5 cDNA (5), produced 
using SP6 RNA polymerase. 
Clone 5 RNA Levels Are Regulated by Cell Density 
and Serum Factors 
The abundance of clone 5 RNA in TA1 adipoblasts increases 
as cells become more dense.  For example, cells harvested 
5 d before confluence (day -5) contain approximately four- 
to sixfold less clone 5 RNA than do cells at day 0 (Fig. 2 A). 
Similarly, when TA1 cells are plated at various dilutions and 
harvested 48 h later, the lower density cells contain less clone 
5 RNA (Fig. 2 B). This could reflect the secretion of an auto- 
crine factor that induces clone 5 RNA and/or the depletion 
of a component in the growth medium that suppresses clone 
5 RNA expression. A strong suggestion that the latter is true 
is afforded by the observation that when cells are fed fresh 
medium, the levels of clone 5 RNA decrease fivefold within 
the  subsequent  24-h period.  Maximal  suppression occurs 
'~16-18 h  after feeding and a  return to the prefed levels of 
clone 5  RNA is seen within 48-72 h  (not shown). 
To test the role of various components of the growth medi- 
um on clone 5  RNA expression we established a  standard- 
ized experimental protocol: TA1 cells were plated at day -5 
or  -4  and 3 d  later the cells were either refed (removal of 
old  medium  followed by  replacement with  fresh  medium 
containing BME  +  10% FCS) or treated by addition of test 
substances directly to the 3-d-old medium.  Control dishes 
were either left undisturbed or refed with 3-d-old medium. 
Total RNA was harvested 24 h later and analyzed for clone 
5  RNA levels.  As seen in Fig.  3 A, the effect of refeeding 
could be duplicated completely by addition of fresh serum. 
To determine what factor(s) in serum might inhibit clone 
5 expression, either modified serum or purified serum com- 
ponents were added to TA! cells in the standardized assay de- 
scribed above. Initial experiments (not shown) indicated that 
whereas dialyzed  serum suppresses  clone 5  RNA  expres- 
sion, charcoal-extracted serum and insulin (at 1 IxM)  do not. 
Fig. 3 A also summarizes the various combinations of com- 
ponents and purified factors that we tested. Both bFGF and 
aFGF as well as PDGF maximally (approximately fivefold) 
suppress clone 5 RNA levels whereas EGF either in the pres- 
ence or absence of insulin does not. As noted above, the sup- 
pression of clone 5 RNA by serum is transient; therefore, we 
tested whether the recovery of clone 5 RNA could be attrib- 
Figure 2. Cell density effects on clone 5 expression.  (A) TA1 cells 
were seeded such that it took 7 d for the cultures to become con- 
fluent. Cultures were refed on days -4 and -2. Total RNA was iso- 
lated from cells on day -5 and day 0. Clone 5 RNA was detected 
by blot  analysis  as  in  Fig.  1.  (B)  Preconfluent  cultures  of TAI 
adipoblasts were trypsinized and divided into three equal aliquots. 
These aliquots were then used to seed four, two, or one tissue cul- 
ture dish(es). 2 d later, cells were harvested, cytoplasmic RNA was 
isolated and analyzed for clone 5 RNA as described  in Fig.  1. 
uted to inactivation of FGF- or PDGF-like material in serum. 
Fresh medium (BME  +  10% FCS) was incubated in tissue 
culture  dishes  (at 37°C,  5%  CO2)  without cells for 24  or 
48 h. As seen in Fig. 3 B preincubated medium loses its abil- 
ity to suppress clone 5 RNA expression, thereby substantiat- 
ing the notion that it is a labile factor in serum that is respon- 
sible for the refeeding effect we have described. 
In light of these results,  one might question conclusions 
derived from the density experiment described earlier (Fig. 
2 B). The higher levels of clone 5 RNA in the denser cultures 
could be attributed to the more rapid consumption of growth 
factors by these cells, followed by an earlier recovery from 
the inhibitory effect on clone 5 expression. To dissociate the 
effect of serum factors on clone 5 expression from the effects 
of cell density, we performed the following experiment: TA1 
adipoblasts  at  day  -1  from two  dishes  were  seeded  into 
twenty dishes, half of which received fresh medium and the 
other half "inactivated" medium which had been incubated 
for 48 h  as described above. As shown in Fig.  4,  the level 
of clone 5 RNA in these cells is reduced fivefold in both cases 
24 h after seeding.  For the cells seeded into fresh medium, 
this reduction in clone 5 RNA could be attributed to serum 
factors.  For the  cells  seeded into aged medium,  the effect 
must be attributed to the effects of change in cell density due 
to  trypsinization,  since  the  medium alone  is  incapable of 
affecting clone 5  levels.  Moreover, we see that the level of 
clone 5 RNA increases as the cells become more dense (at 
48  and  72  h).  Once  again,  this  cannot be attributed  to  a 
recovery from inhibition by serum. By 72 h,  the cells have 
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ponents and purified  factors.  TA1 cells were treated on day -2 or 
-1 with the indicated agents. 24 h later, cytoplasmic  RNA was iso- 
lated from the cells  and quantitatively  analyzed for clone 5 RNA 
levels using  the "slot blot" technique  described  in Materials  and 
Methods.  In all cases,  cells  were seeded on day -5 and not refed 
unless indicated below. (A) The added components were 10% FCS, 
aFGF at  10 ng/ml,  bFGF at  1.0 or 0.1 ng/ml,  PDGF at  10 ng/ml, 
100 ng/ml EGF in the presence or absence of I taM insulin,  or un- 
treated cells (NT). (B) On day -2, medium was removed from TA1 
ceils, which were refed with medium pretreated  for 24 or 48 h (see 
text), or with the same medium which was just removed from the 
dish. RNA was analyzed as above. (C) Inhibition by direct activators 
of PKC. On day  -2 or -1, the indicated  compound was added to 
the cells and RNA isolated 24 h later. The tested agents were 1 ~Vl 
phorbol dibutyrate  (PDB) or TPA at the concentrations  shown. In 
the case of diC8, cells were treated initially with 50 }xM (50/20) or 
2 ~tM (2/2) diC8, and then treated  six more times,  every 2 h with 
20 ~tM (50/20)  or 2 p.M (2/2) diCs. Cells were harvested  18 h af- 
ter the initial treatment  and analyzed for clone 5 RNA as described 
above. 
returned to the density of day -1 cells, and clone 5 RNA has 
also returned  to its previous level. 
It  is  particularly  noteworthy  that  the  effect  of FGF  or 
PDGF on clone 5 expression occurs in actively growing cells 
and that  serum,  depleted  of clone  5  inhibiting  activity by 
treatment with charcoal or preincubation,  still supports the 
active growth of TA1 ceils. Thus it appears that the suppres- 
sion of clone 5  gene expression is not simply due to mito- 
genic stimulation of the cells. 
A Role  for PKC in Control of  Clone 5 Gene Expression 
Both bFGF and PDGF have been shown to induce turnover 
of  phosphatidylinositol  thereby  generating  diacylglycerol 
and inositol triphosphate  (Habenicht et al.,  1981;  Tsuda et 
al.,  1985).  Since  many of the  actions  of these  hormones 
seem to be mediated by activation of  PKC with diacylglycerol 
(Berridge,  1984;  Nishizuka,  1984)  we tested  whether  this 
might also be true of clone 5 RNA expression.  Addition of 
exogenous activators of PKC, such as the phorbol esters TPA 
or phorbol dibutyrate to TA1 cells led to a dramatic reduction 
of clone 5 RNA levels (Fig. 3 C). The concentration of TPA 
required to suppress clone 5 RNA expression is in the range 
reported to be sufficient to activate PKC (Nishizuka,  1984). 
Finally, the use of diCs,  when applied at dosages known to 
activate PKC in other systems (Ebeling et al.,  1985, Ganong 
et al.,  1986) also reduces clone 5 expression to the same ex- 
tent as serum (Fig.  3  C).  Thus we surmise that the ability 
of FGF and PDGF to inhibit clone 5 gene expression is most 
likely due to the activation of PKC, though other signal trans- 
duction pathways may also play a  role. 
Growth Factor Inhibition of TA1 Cell Differentiation 
TA1  adipoblasts  will  not differentiate  if maintained  at low 
density (Knight et al., 1987) or if chronically stimulated with 
fresh complete medium (Chapman,  1986).  Under the latter 
situation the cells continue to proliferate and do not express 
any markers of the differentiated phenotype. To test whether 
any of the growth factors that suppress clone 5 gene expres- 
sion interfere with differentiation, TA1 cells were induced to 
differentiate by addition of indomethacin at day 0. In the ab- 
sence of any further additions  >95%  of the cells differen- 
tiated within 3 d as determined by detection of accumulated 
lipids with oil red O (not shown) and induced active expres- 
sion of clone 28 RNA (Fig. 5 A). However, addition of 10% 
FCS, bFGE or TPA every 24 h  suppresses the induction of 
clone 28 RNA at day 3 (Fig. 5 A) and morphological differ- 
entiation of the cells (not shown).  In contrast,  neither EGF 
nor low concentrations of serum have much effect on the ac- 
cumulation of clone 28 RNA. By slightly altering the differ- 
entiation assay,  we can accentuate the inhibitory  effects of 
bFGF and TPA on adipocyte differentiation.  In the experi- 
ment  shown  in  Fig.  5  B,  the  cells  were  refed  1  d  before 
confluence.  Indomethacin was added on day 0,  along with 
bFGF or TPA.  The daily addition of bFGF (1.0 ng/ml) or 
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Figure 4. Effect of cell density on 
clone  5  expression  uncoupled 
from  the  refeeding  effect.  TA1 
cells (not fed since seeding at day 
-5) at day  -1 were split into  10 
dishes,  fed with either fresh me- 
dium or medium incubated at 3"/°C 
in 5 % CO2 without cells for 48 h 
(see text). RNA was isolated from 
the initial day  -1 cells  (zx at day 
0  =  100) and  24, 48,  and  72 h 
later  from  the  cells  seeded  in 
fresh  (D)  or  aged  (o)  medium. 
Clone 5 levels were  analyzed as 
in Fig.  3. 
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growth factors. (A) Cultures of TA1 cells (not fed since seeding at 
day  -5)  were  refed and  treated  with  indomethacin  on reaching 
confluence (day 0). In addition,  the cells were treated with either 
10% serum,  1% serum, bFGF at 10 ng/ml,  1 IJ.M  TPA, or no treat- 
ment (NT). These additions (but not indomethacin) were repeated 
on days  1 and 2.  RNA was isolated on day 3, and the extent of 
differentiation determined by analyzing clone 28 levels (as in Fig. 
1). (B) TA1 cells (not fed since seeding at day -5) were refed on 
day  -1  and treated with indomethacin upon reaching confluence 
(day 0).  Highly purified bFGF at l ng/ml or 0.1 ng/ml, or TPA at 
100 or I nM were added along with the indomethacin, and repeated 
on days 1 and 2. RNA was isolated on day 3 and the extent of dif- 
ferentiation determined by analyzing the levels of clones  1 and 28. 
TPA  (100  nM)  significantly  suppressed  the  expression  of 
the RNAs corresponding to clone 28 and clone  1 (another 
adipocyte-specific cDNA used for monitoring differentiation 
[Chapman et al.,  1984]).  When applied at concentrations 
that do not inhibit clone 5  expression (Fig.  3),  bFGF (0.1 
ng/ml) and TPA (1  nM)  did  not affect adipogenesis.  Thus 
those  agents  that  (at  appropriate  concentrations)  inhibit 
clone  5  RNA  expression  are  also  those  that  suppress 
differentiation of TA1 cells. 
The inhibition of differentiation by the various agents de- 
scribed  above  could  be  explained  if the  adipoblasts  are 
stimulated to reenter the cell cycle and proliferate. In the case 
of daily additions of serum, this appears to be what happens. 
At the time of harvest,  serum-treated cultures consistently 
have two- to threefold the number of cells per dish (2.6  × 
10  ~ cells/plate) as the untreated cells (1.1  ×  106 cells/plate). 
In contrast, TA1 cultures treated with bFGF or TPA have the 
same number of cells as the untreated cultures (1.1  x  106 
and 0.9  x  106 cells/plate, respectively). Thus, as is true for 
suppression of clone 5 RNA, inhibition of differentiation by 
growth  factors  or  TPA  cannot  be  attributed  to  mitogenic 
stimulation through the cell cycle. 
Sequence of  the Clone 5 cDNA 
To characterize the clone 5 gene product, we rescreened the 
TA1  adipocyte cDNA library prepared by Chapman et al. 
(1984)  and isolated a  clone containing an insert of "~1,000 
base pairs  (the mRNA is  "~1.1 kb in  length). 2 The inserts 
2. These sequence data  have been submitted  to the EMBL/GenBank Data 
Libraries under the accession number X07411. 
i0  20  30  40  50 
ACCAGCATGAAGCTGAATTTCAGTGGCCTGAGGGCCCTGGTGACAGGGGCA 
MetLysLeuAsnPheSerGlyLeuArgAlaLeuValThrGlyA1a 
60  70  80  90  100 
GGGAAAGGGATTGGACGGGACACTGTGAAGGCCCTGCACGCCTQAGGAGCC 
G1yLysGlyI1eGlyArgAspThrValLysAlaLeuHisAlaSerGlyAla 
110  120  130  140  150 
AAAGTGGTGGCGGTGACTCGGACCAACTCAGACCTGGTCAGCCTTGCCAAA 
LysValValAlaVa~ThrArgThrAsnSerAspLeuValSerLeuA1aLys 
160  170  180  190  200 
GAGTGTCCCGGAATAGAGCCCGTGTGTGTGGACCTGGGTGACTGGGATGCC 
GluCysProGlyIleGluProValCysValAspLeuG1yAspTrpA3pAla 
210  220  230  240  250 
ACAGAGAAGGCGCTGGGCGGTATCGGCCCTGTGGACTTACTGGTGAACAAT 
ThrGluLysAlaLeuGlyGlyIleGlyProValAspLeuLeuValAsnAsn 
260  270  280  290  300 
GCAGCGCTGGTTATAATGCAGCCCTTCCTGGAAGTTACCAAGGAAGCCTTT 
AlaAlaLeuValI1eMetGlnProPheLeuGluValThrLysGluAlaPhe 
310  320  330  340  350 
GACAGGTCCTTCAGTGTAAATCTTCGCTCTGTGTTTCAGGTATCCCAGATG 
AspArgSerPheSerValAsnLeuArgSerValPheGlnVaISerGlnMet 
360  370  380  390  400 
GTAGCCAGGGACATGATTAACCGTGGCGTGCCAGGGTCCATTGTCAATGTC 
ValAlaArgAspMetIleAsnArgGlyValProGlySerIleValAsnVal 
411  420  430  44D  450 
TCCAGCATGGTGGCCCATGTCACCTTTCCTAACTTGATCACCTACAGCTCC 
SerSerMetValAlaHisValThrPheProAsnLeuIleThrTyrSerSer 
4~0  480  490  500  510 
ACCAAGGGAGCGATGACTATGCTGACCAAAGCCATGGCCATGGAACTAGGG 
ThrLysGlyAlaMetThrMetLeuThrLysAlaMetAlaMetGluLeuGly 
520  530  540  550  560 
CCACACAAGATCCGGGTAAACTCCGTAAACCCCACTGTGGTGCTGACTGAC 
ProHisLysIleArgValAsnSerValAsnProThrValValLeuThrAsp 
570  580  590  600  610 
ATGGGCAAGAAAGTCTCTGCAGACCCTGAGTTTGCCAGGAAGCTCAAGGAG 
MetG1yLysLysValSerAlaAspProGluPheAlaArgLysLeuLysG1u 
620  630  640  650  660 
CGCCACCCACTGAGGAAGTTCGCAGAGGTTGAAGACGTCGTCAACAGCATC 
ArgHisProLeuArgLysPheAlaGluValGluAspValValAsnSerIle 
670  680  690  ?00  710 
CTCTTCCTGCTCAGCGACAGAAGTGCCTCTACCAGTGGCGGTGGCATCCTG 
LeuPheLeuLeuSerAspArgSerAlaSerThrSerGlyGlyGlyIleLeu 
720  730  740  750  760 
GTGGATGCTGGCTACCTGGCCTCCTAGTCTGCTCAGTTGCCGCGGACATCT 
ValAspAlaGlyTyrLeuAlaSer*** 
770  780  790  800  810 
GAGTGGCCTTCTTAGCCCCACCCTCAGCCAAAGCATTTACTGATCTCGTGA 
820  830  840  850  860 
CTCCGCCCTCATGCTACAGCCACGCCCACCACGCAGCTCACAGTTCCACCC 
870  880  890  900  910 
CCATGTTACTGTCGATCCCACAACCACTCCAGGCGCAGACCTTGTTCTCTT 
921  930  940  950  960 
TGTCCACTTTGTTGGGCTCATTTGCCTAAATAA~CGGGCCACCGCG 
Figure 6. Nucleotide sequence of clone 5 cDNA. The sequence is 
numbered from the 5' end of the cDNA clone. Translation of the 
open reading proposed to be the clone 5 gene product is shown be- 
low the nucleotide sequence and encodes a peptide of 244 amino 
acids.  The putative  polyadenylation  site  (AAATAAA) is under- 
lined. 
were subcloned into a plasmid vector and the nucleotide se- 
quence was determined (Fig. 6) by the method of Sanger et 
al.  (1977).  An open reading  frame of 244 amino acids is 
present within the clone 5 cDNA as is the canonical polyade- 
nylation signal AATAAA. Comparison of the DNA sequence 
with known sequences  in the  Genbank DNA database re- 
vealed no  significant homologies.  However, the  translated 
amino acid sequence, 3 when compared to the National Bio- 
medical  Research  Foundation  protein  database,  revealed 
significant  homology  between  the  clone  5  open  reading 
frame and ribitol dehydrogenase of Enterobacter  aerogenes 
(Morris et al.,  1974)  (Fig. 7).  The most striking homology 
resides between amino acids 10 and 35, a region that exhibits 
a resemblance to the NAD-binding domain of other dehydro- 
genases and to ATP-binding proteins. Particularly notewor- 
thy are the residues 14-21 (GAGKGIGR) which are followed 
3. These sequence data  have been submitJced to the EMBL/GenBank Data 
Libraries. 
Navre and Ringold Growth Factor-repressible Gene in Adipocytes  283 10  20  30  40  50 
MKLNF SGLRALVTGAGKG  IGRDTVKALHASGAKVVAVTRTNSDLVS  LAKECPG 
10  20  30  40  50 
60  70  80  90  100 
IEPVC- -VDLGDWDATEKALGGI  ....  GPVD LLVNNAALVIMQPFLEVTKEAFDRSFSVN 
:::  :  :  ::  :  :  ::  :  :  l  ::  : 
QNAF  ALQVD LMQADQVDNLLQG  I  LQLTGRLD  IFHANAGAY  I  GGPVAEGDPDVWDRVLH  LN 
70  80  90  100  110 
120  130  140  150 
L  ....... RSVF ..... QVSQMVARDMINRGVPGS  IVNVS SMVAHVTFPNLI  TYS  S  TKGA 
:::  :  :  :  :  :  :  :  :  :  :  :  : 
I  NAAF RCVRSVLP H  LLAQKSG ....  DI  XFTAV---IAGV  ...... VXWEPVYTAS  --KFA 
130  140  150  160 
160  170  180  190  200 
M  ...... TMLTKAMAMELGP  HK  I  RVN  SVNP  T  -W-  -  LTDMGKKVSADPEFARKLKERHp  L 
:  :  :  ::  :  :  ::  :  :  :  :  :  : 
VQAFVHTTRRQVAQY-  -  -GV-- -RVGAVLP GPVVTALLDDWP  KAKMDEALADGS  ..... L 
170  180  190  200  210 
220  230  240 
RKFAEV-EDVVNS  I  LFLLSDRSAS-TSGGG-  I  L---VDAGYLAS 
MQP IEV~S;  ....  :LFMVT-RSKN~VRD  IV  :ILPNS~L 
220  230  240 
Figure  7.  Amino acid sequence homology between the putative 
clone 5 protein and E. aerogenes ribitol dehydrogenase (Moore et 
al., 1978). The upper line shows the sequence of the clone 5 open 
reading frame; the lower line shows the ribitol dehydrogenase se- 
quence. The numbering for each sequence is also shown. : indicates 
identical amino acid matches. The match was prepared using the 
BIONET program ALIGN. 
12 amino acids later by lysine; this motif is characteristic of 
the  ATP-binding  domains  of various  protein kinases  and 
ATPases (Kamps et al.,  1984). 
Discussion 
That hormones control aspects of differentiation has  long 
been assumed to be true. It is only recently, however, that 
well-defined systems have become available to study the mo- 
lecular and biochemical details associated with differentia- 
tion. In the case of steroid hormones, whose receptors act 
as regulators of gene transcription (Yamamoto, 1985), effects 
on differentiation are presumed to depend on activation (or 
perhaps  repression)  of regulatory  genes  (Ringold,  1985) 
whose products control one or more critical  steps  in the 
differentiation process. 
We have previously documented that glucocorticoid hor- 
mones accelerate the conversion of preadipocytes to adipo- 
cytes in the cell line TA1 (Chapman et al.,  1985, Knight et 
al.,  1987). The hormonal effect is associated with the pre- 
cocious activation of adipocyte-specific gene transcription 
whereas the absolute level of gene expression that is eventu- 
ally achieved is equivalent in the presence or absence of hor- 
mone. Thus we have hypothesized that glucocorticoids regu- 
late a gene(s) whose product is intimately associated with the 
triggering of the conversion from preadipocytes to adipo- 
cytes; such a gene product would need to reach a threshold 
level to initiate the biochemical processes associated with 
differentiation (Ringold et al.,  1986). 
While glucocorticoids regulate the rate at which the TA1 
cells progress to the differentiated state, other environmental 
factors influence the decision to continue proliferation or to 
withdraw  from the cell cycle in a  manner permissive for 
differentiation. Knight et al. (1987) have for example demon- 
strated that preconfluent cultures of TA1 cells show little ten- 
dency to differentiate, even in the presence of strong inducers 
of differentiation. Thus factors associated with high cell den- 
sity are critical in the decision to differentiate.  Similarly, 
chronic mitogenic stimulation acts as a negative regulator of 
differentiation.  As  shown  here and  elsewhere (Chapman, 
1986), confluent cultures of TA1 cells stimulated daily by se- 
rum continue to proliferate and do not undergo adipogenesis, 
even in the presence of indomethacin. The inability of cells 
to differentiate while mitogenically stimulated is not peculiar 
to adipocytes and may well be a general phenomenon. 
In this paper we have described several characteristics of 
clone 5 RNA expression that suggest the product of this gene 
might play a regulatory function in the conversion of adipo- 
blasts to adipocytes. In particular, environmental factors that 
stimulate adipogenic differentiation such as glucocorticoids 
and  high  cell density  increase the  expression of clone 5 
RNA. Moreover, factors that inhibit clone 5 expression such 
as bFGF or phorbol esters also inhibit adipogenic differenti- 
ation. 
Some aspects of the control of clone 5 gene expression by 
growth factors deserve particular attention. First, the direct 
inhibition of gene expression by bFGF and PDGF (i.e., not 
separable from indirect effects on differentiation-dependent 
gene expression) has not, to the best of our knowledge, been 
actively studied. Our results suggest that, as is the case for 
PDGF-mediated induction of c-myc and c-fos (Coughlin et 
al.,  1985;  Kaibuchi et al.,  1986), the repression of clone 5 
expression by bFGF or PDGF is mediated by activation of 
PKC. Second, the effects of bFGF or PDGF on clone 5 ex- 
pression appear to be separable from their mitogenic activ- 
ity. Suppression of clone 5 gene expression by these growth 
factors (or TPA) occurs in TA1 cells already stimulated to 
grow by serum mitogens. Similarly, the inhibition of differ- 
entiation by these same agents occurs under conditions in 
which they do not stimulate cell growth. It therefore seems 
clear that the inhibition of TA1 cell differentiation by bFGF 
or TPA cannot simply be ascribed to the mitogenic activity 
of these agents. 
The finding that known mitogens inhibit adipogenic differ- 
entiation without inducing cell proliferation is not unique to 
the TA1 cell type. Similar results have been observed with 
another adipogenic cell line, 3T3-L1.  Hayashi et al.  (1981) 
demonstrated that the addition of highly purified bFGF or 
PDGF to 3T3-L1  adipoblasts inhibited adipogenic conver- 
sion. On the other hand, EGF, even at high concentration, 
had no effect on 3T3-L1 differentiation. Moreover, the authors 
noted that bFGF and PDGF, both mitogens of 3T3 cells, also 
had little effect if any on cell multiplication under the assay 
conditions used. Similarly, Diamond et al. (1977) and Shi- 
mizu et al.  (1983)  have shown that TPA treatment of 3T3 
adipocytes also  inhibits  adipogenesis.  These authors  also 
found that the addition of TPA to 3T3 preadipocytes did not 
force those cells to divide. Thus the mechanisms by which 
these factors inhibit differentiation appears to be independent 
of their effects on cell proliferation. 
The effect of  growth factors on differentiation is not limited 
to adipogenic lines.  The differentiation of many myogenic 
cell lines has been shown to be sensitive to FGE As an exam- 
ple, Clegg et al.  (1987), while studying the FGF-mediated 
inhibition of MM14 myoblast differentiation, found that in 
the absence of serum, FGF would block myogenesis without 
inducing cell replication, causing the cells to stop cycling in 
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have shown aFGF can dedifferentiate the reversibly differen- 
tiated myogenic cell line, BC3H1.  As with the MM14 myo- 
blasts,  the addition of FGF to these cells  does  not induce 
them to traverse the S phase of the cell cycle when kept quies- 
cent  under  low  serum  conditions.  Indeed  Lathrop  et  al. 
(1985b) have provided evidence that aFGF causes quiescent 
BC3H1  myoblasts to exit from Go (a point in the cell cycle 
permissive for differentiation) and to become restricted at a 
new point in G1 where the cells are incapable of expressing 
the differentiated phenotype. 
All of these results indicate that factors known to activate 
PKC are capable of suppressing the differentiated phenotype 
in several cell types, but without affecting cell proliferation. 
Thus it could be proposed that it is the growth factor recep- 
tor-mediated activation of PKC that inhibits differentiation. 
Currently, there is no well-defined role for PKC activity in 
cells where it is activated by mitogenic factors. For example, 
it has been shown that while FGF and PDGF activate PKC 
in many fibroblast lines, depletion of the enzyme by phorbol 
ester pretreatment of the cells does not eliminate the mito- 
genic potential of the peptides (Coughlin et al.,  1985; Kai- 
buchi et al.,  1986). We would suggest that the role of PKC 
activation in these cells is to convey a signal that cell cycle 
withdrawal (entry into Go) is not permissible. In the specific 
case of TA1  (and possibly 3T3-L1)  cells,  this might be ac- 
complished by the down-regulation of clone 5 RNA levels. 
The data presented here provide a strong association be- 
tween clone 5 RNA expression and the ability of TA1 cells 
to differentiate. However, direct tests will be required to as- 
sess whether the expression of the clone 5 gene product at 
a  certain  threshold level  is  required  for  the triggering  of 
adipocyte differentiation. Identification of the clone 5 protein 
and determination of its  intrinsic enzymatic or regulatory 
functions present avenues for further investigation. 
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